The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Oral misoprostol for induction of labour
Open accessAbstract
BACKGROUND: Misoprostol is an orally active prostaglandin. In most countries misoprostol is not licensed for labour induction, but its use is common because it is cheap and heat stable. OBJECTIVES: To assess the use of oral misoprostol for labour induction in women with a viable fetus. SEARCH METHODS: We searched the Cochrane Pregnancy and Childbirth Group's Trials Register (17 January 2014). SELECTION CRITERIA: Randomised trials comparing oral misoprostol versus placebo or other methods, given to women with a viable fetus for labour induction. DATA COLLECTION AND ANALYSIS: Two review authors independently assessed trial data, using centrally-designed data sheets. MAIN RESULTS: Overall there were 76 trials (14,412) women) which were of mixed quality.In nine trials comparing oral misoprostol with placebo (1109 women), women using oral misoprostol were more likely to give birth vaginally within 24 hours (risk ratio (RR) 0.16, 95% confidence interval (CI) 0.05 to 0.49; one trial; 96 women), need less oxytocin (RR 0.42, 95% CI 0.37 to 0.49; seven trials; 933 women) and have a lower caesarean section rate (RR 0.72, 95% CI 0.54 to 0.95; eight trials; 1029 women).In 12 trials comparing oral misoprostol with vaginal dinoprostone (3859 women), women given oral misoprostol were less likely to need a caesarean section (RR 0.88, 95% CI 0.78 to 0.99; 11 trials; 3592 women). There was some evidence that they had slower inductions, but there were no other statistically significant differences.Nine trials (1282 women) compared oral misoprostol with intravenous oxytocin. The caesarean section rate was significantly lower in women who received oral misoprostol (RR 0.77, 95% CI 0.60 to 0.98; nine trials; 1282 women), but they had increased rates of meconium-stained liquor (RR 1.65, 95% CI 1.04 to 2.60; seven trials; 1172 women).Thirty-seven trials (6417 women) compared oral and vaginal misoprostol and found no statistically significant difference in the primary outcomes of serious neonatal morbidity/death or serious maternal morbidity or death. The results for vaginal birth not achieved in 24 hours, uterine hyperstimulation with fetal heart rate (FHR) changes, and caesarean section were highly heterogenous - for uterine hyperstimulation with FHR changes this was related to dosage with lower rates in those with lower doses of oral misoprostol. However, there were fewer babies born with a low Apgar score in the oral group (RR 0.60, 95% CI 0.44 to 0.82; 19 trials; 4009 babies) and a decrease in postpartum haemorrhage (RR 0.57, 95% CI 0.34 to 0.95; 10 trials; 1478 women). However, the oral misoprostol group had an increase in meconium-stained liquor (RR 1.22, 95% CI 1.03 to 1.44; 24 trials; 3634 women). AUTHORS' CONCLUSIONS: Oral misoprostol as an induction agent is effective at achieving vaginal birth. It is more effective than placebo, as effective as vaginal misoprostol and results in fewer caesarean sections than vaginal dinoprostone or oxytocin.Where misoprostol remains unlicensed for the induction of labour, many practitioners will prefer to use a licensed product like dinoprostone. If using oral misoprostol, the evidence suggests that the dose should be 20 to 25 mcg in solution. Given that safety is the primary concern, the evidence supports the use of oral regimens over vaginal regimens. This is especially important in situations where the risk of ascending infection is high and the lack of staff means that women cannot be intensely monitored.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Moher, D., Pham, B., Jones, A., Cook, D. J., Jadad, A. R., Moher, M., Tugwell, P., & Klassen, T. P. (1998) · The Lancet · doi:10.1016/s0140-6736(98)01085-x · Cited by 3,560
Cited by
Induction of labour for improving birth outcomes for women at or beyond term
Middleton, P., Shepherd, E., & Crowther, C. A. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004945.pub4 · Cited by 667
Mechanical methods for induction of labour
Jozwiak, M., Bloemenkamp, K. W., Kelly, A. J., Mol, B. W. J., Irion, O., & Boulvain, M. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001233.pub2 · Cited by 536
Induction of labour for improving birth outcomes for women at or beyond term
Gülmezoglu, A. M., Crowther, C. A., Middleton, P., & Heatley, E. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004945.pub3 · Cited by 411
Leduc, D., Biringer, A., Lee, L., Dy, J., Corbett, T., Leduc, D., Biringer, A., Duperron, L., Dy, J., Lange, I., et al. (2013) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/s1701-2163(15)30842-2 · Cited by 347
Intravenous oxytocin alone for cervical ripening and induction of labour
Alfirevic, Z., Kelly, A. J., & Dowswell, T. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003246.pub2 · Cited by 255
Self-citation
Metadata
- Authors
- Alfirevic, Z., & Weeks, A.
- Venue
- Cochrane Database of Systematic Reviews
- Publisher
- John Wiley & Sons, Ltd
- Published
- 2006-04-19
- Issue
- 2
- Pages
- CD001338-CD001338
- ISSN
- 1361-6137 (ISSN-L)
- OpenAlex
- W2113529708
- Cited by
- 331
- References
- 1
- Type
- reference entry
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Oral misoprostol for induction of labour. https://app.cochat.ai/papers/10.1002/14651858.cd001338.pub2
- The paper
- Alfirevic, Z., & Weeks, A. (2006). Oral misoprostol for induction of labour. Cochrane Database of Systematic Reviews. https://doi.org/10.1002/14651858.cd001338.pub2
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.